Nordic Pharma Consulting ApS: Financial statements 2019
CVR: 37368598
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 8,594,718 and a net result of DKK 751,731 compared with DKK 492,599 the year before. That is an increase of 23.4% compared with the year before. Equity in the 2019 report amounted to DKK 802,597. The solvency ratio was 36%.
- Gross Profit
- DKK 8,594,718
- Profit/Loss
- DKK 751,731
- Equity
- DKK 802,597
- Total Assets
- DKK 2,230,526
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 8.6M | 752K | 803K | - |
| 2018 | - | 7M | 493K | 748K | - |
| 2017 | - | 6M | 785K | 855K | - |
| 2016 | - | 1.7M | 620K | 670K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Nordic Pharma Consulting ApS has published its annual report for 2018. Gross profit came to DKK 6,963,201, and the net result was DKK 492,599.
As of January 7, 2019, Ray David Sossna is registered as director of Nordic Pharma Consulting ApS.
As of January 7, 2019, by.david ApS is registered as an owner of Nordic Pharma Consulting ApS with an ownership share of 33%.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.